Warfarin Use Is Associated with Increased Mortality at One Year in Patients with Idiopathic Pulmonary Fibrosis

OBJECTIVES: We studied the safety and efficacy of warfarin compared to direct acting oral anticoagulant use in patients with IPF. METHODS: We conducted a retrospective cohort study of all patients with IPF who were prescribed warfarin or direct acting oral anticoagulants (DOACs) for cardiac or throm...

Descripción completa

Detalles Bibliográficos
Autores principales: Naqvi, Syeda Fatima, Sohail, Amir Humza, Lakhani, Dhairya A., Maurer, James, Sofka, Sarah, Hadi, Yousaf B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639231/
https://www.ncbi.nlm.nih.gov/pubmed/34868680
http://dx.doi.org/10.1155/2021/3432362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639231/
https://www.ncbi.nlm.nih.gov/pubmed/34868680
http://dx.doi.org/10.1155/2021/3432362

Ejemplares similares